Gynuity’s President Honored with Special Award of Recognition for Contributions to Safe Abortion Access

Beverly Winikoff, MD, MPH, has been presented with a Special Award of Recognition by the Georgian Society of Contraception and Reproductive Health for her significant contributions to improving safe abortion access in the Republic of Georgia. This accolade is awarded infrequently by the Society and is reserved for individuals whose work has had a real transformative effect.

Throughout her career, Beverly has used research to fill information gaps, improve services and patient experiences, and strengthen access to care. Gynuity’s initiatives in Georgia have included undertaking clinical studies on medication abortion, disseminating research findings, delivering training to health professionals, developing educational resources for both women and providers, and providing support to local experts on updates for national abortion guidelines.

Tamar Tsereteli accepted the award on behalf of Beverly at the Society’s annual conference in Tbilisi. We recognize Tamar’s key role in managing Gynuity’s projects in Eastern Europe and Central Asia.

About Beverly Winikoff

Beverly Winikoff is President of Gynuity Health Projects. Before founding Gynuity, Beverly was employed at the Population Council where she was director for reproductive health and a senior medical associate. She graduated from Harvard University magna cum laude and earned her Doctor of Medicine (MD) degree from New York University and her Master of Public Health (MPH) degree from the Harvard School of Public Health.

About Gynuity Health Projects

Gynuity Health Projects is a distinguished non-profit organization committed to expanding the availability of new and existing reproductive health technologies at reasonable cost, provided within high-quality service frameworks that respect individual dignity and rights. Since its establishment in 2003, Gynuity has engaged with service providers, clinical researchers and health advocates worldwide to conduct pioneering research on medication abortion, contraception and obstetric complications and promote evidence-based policies and practices that enhance access to care.